Nano-X Imaging (NNOX) FDA Submission a 'Significant Regulatory Step' - Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Ladenburg Thalmann Reiterates Buy Rating on Nano-X Imaging (NNOX) on 510(k) Submission
June 17, 2021 10:03 AM EDTLadenburg Thalmann analyst Jeffrey Cohen reiterated a Buy rating and $52.00 price target on Nano-X Imaging (NASDAQ: NNOX) after the company announced a 510(k) submission for the first version of the multisource Nanox-ARC digital tomosynthesis system to the FDA.
Cohen notes the typcical review... More
Nanox (NNOX) Announces FDA 510(k) Submission for First Version of Multi-Source Nanox.ARC
June 17, 2021 7:39 AM EDTNANOX IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, announced today that the Company has submitted a 510(k) premarket notification application to the U.S. Food and Drug Administration (FDA) for the first version of its multi-source Nanox.ARC 3-D digital tomosynthesis system.
... More



